Informace o projektu
Next Generation Sequencing Platform for Targeted Personalized Therapy of Leukemia (NGS-PTL)

Logo poskytovatele
Kód projektu
7E13008
Období řešení
9/2013 - 10/2015
Investor / Programový rámec / typ projektu
Ministerstvo školství, mládeže a tělovýchovy ČR
Fakulta / Pracoviště MU
Středoevropský technologický institut

This project aims at developing a European Hematological/HTS platform of scientists for improving outcomes for therapeutic interventions on acute and chronic leukemias and at develop strategies to personalize treatments and tailor therapies to different stratified groups of leukemia patients, with the goal of optimizing their efficacy and safety through a deeper and deeper understanding of the influence of genetic/genomic alterations on leukemias pathogenesis and treatment response (i.e. “personalized therapy”). Moreover, the final aim will be the identification of novel prognostic biomarkers for acute and chronic leukemias, as well as of molecular biomarkers and/or genomic profiles for the assessment of minimal residual disease. The originality of this project is to perform systematic deep genomic/transcriptomic studies on well-clinically-characterized leukemia patients, by exploiting HTS technologies able to quickly produce data with a good cost-effectiveness and an unprecedented resolution.

Publikace

Počet publikací: 23


Předchozí 1 2 3 Další

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info